AzTrials
AzTrials

Neurologic DeficitsMI-BA-JPSNCT07445165

Investigation of Motor Imagery Ability in Relation to Body Awareness and Joint Position Sense in Healthy Subjects

An observational study of Neurologic Deficits, run by Istanbul Arel University at 1 site in Turkey (Türkiye).

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Motor imagery (MI) is a dynamic mental state in which representations of a specific motor movement are rehearsed in working memory without any movement manifestation. It is practiced in physiotherapy clinics to improve motor performance and learn motor tasks. Read more about this study

Who is it for?
Ages 20 to 40 yearsHealthy volunteers can take part
Conditions the study is for
Neurologic Deficits
What is being tested?
Movement Imagery Questionnaire-3 (MIQ-3), Vividness of Movement Imagery Questionnaire-2 (VMIQ-2) and The Recognise™
How many people
37 participants
Where
1 siteTurkey (Türkiye)
Study dates
12 Nov 2022to 29 Jun 2023
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 20 to 40 years
  • All sexes
  • Healthy volunteers accepted
  • Adult

Study population: The study population consisted of healthy adult individuals aged between 18 and 35 years who had no history of neurological, orthopedic, or sensory disorders that could affect motor imagery ability, body awareness, or joint position sense. Participants were volunteers recruited from university students and staff.

Who may be able to join

  • Volunteering to participate in the study
  • Aged between 20-40 years old
  • Having a Standardized Mini-Mental State Examination score higher than 24 points.

Who cannot join

  • Having any musculoskeletal system disease
  • Having any chronic disease
  • Having a history of physical trauma
  • Cognitive impairment
  • Having a neurological problem
  • Using analgecis for a long time
  • Having a complaint of pain during the evaluation
  • Using sedatives and/or antidepressants

Trial locations and contacts

1 site in 1 country.

Turkey (Türkiye)1 site
  • Arel University

    Istanbul, Zeytinburnu, 34015

Other trials in Turkey (Türkiye)

About this study

Motor imagery (MI) is a dynamic mental state in which representations of a specific motor movement are rehearsed in working memory without any movement manifestation. It is practiced in physiotherapy clinics to improve motor performance and learn motor tasks. Since the efficiency of the practice depends on the quality of imagery, it is necessary to assess imagery ability before performing an imagery experiment or participating in an imagery training program.

Body awareness is used as a general concept for body management, body experience and body use. It contains information about the parts of the body and includes position perception, movement sense and the conditions required for movements, mental elements (cognitive thought processes). Joint position sense, which has an important role in postural control, is defined as being aware of the position and movement of the joint in space by the central nervous system. Although it has been shown that there are factors related to the central nervous system such as cognitive level that affect motor imagery ability, there are no studies showing the relationship between body awareness and joint position sense, in which central nervous and sensory systems work in integration, and motor imagery ability. In this study, motor imagery ability will be evaluated in healthy subjects and its relationship with body awareness and joint position sense will be investigated.

Being tested
Movement Imagery Questionnaire-3 (MIQ-3), Vividness of Movement Imagery Questionnaire-2 (VMIQ-2), The Recognise™, Body Awareness Questionnaire
Keywords
Body Awareness, Motor Imagery, Laterization
Medical subject headings
Neurologic Manifestations

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Movement Imagery Questionnaire-3 (MIQ-3)Other

    This is a scale.

  • Vividness of Movement Imagery Questionnaire-2 (VMIQ-2)Other

    This is a scale.

  • The Recognise™Other

    This outcomes is mobile application. We used by assesment brain lateralisation skills.

  • Body Awareness QuestionnaireOther

    This is a scale.

Study groups in NCT07445165
Study groupRoleWhat they receive
Only assessment researchNot described
Receives: Other: Movement Imagery Questionnaire-3 (MIQ-3); Other: Vividness of Movement Imagery Questionnaire-2 (VMIQ-2); Other: The Recognise™; Other: Body Awareness Questionnaire

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Motor Imagery Ability Assessed by the Movement Imagery Questionnaire-3 (MIQ-3)

    Explicit motor imagery ability will be assessed using the Movement Imagery Questionnaire-3 (MIQ-3). The MIQ-3 evaluates individuals' ability to imagine movements from visual and kinesthetic perspectives using self-reported ratings. The total MIQ-3 score will be used for analysis.

    Measured: At baseline (single assessment at study enrollment)

  2. Body Awareness Assessed by the Body Awareness Questionnaire (BAQ)

    Body awareness will be assessed using the Body Awareness Questionnaire (BAQ), a self-report instrument designed to evaluate individuals' awareness of bodily processes, postural changes, and internal bodily sensations. The total BAQ score will be calculated and used for statistical analysis.

    Measured: At baseline (single assessment at study enrollment)

  3. Motor Imagery Ability Assessed by the Vividness of Movement Imagery Questionnaire-2 (VMIQ-2)

    Explicit motor imagery vividness will be assessed using the Vividness of Movement Imagery Questionnaire-2 (VMIQ-2). The VMIQ-2 measures the vividness of visual and kinesthetic motor imagery through self-reported responses. Subscale and total scores will be used for statistical analysis.

    Measured: At baseline (single assessment at study enrollment)

Secondary outcomes (1)
  1. Implicit Motor Imagery Assessed by the Hand Laterality Judgment Task (Recognise™)

    Implicit motor imagery ability will be assessed using the Hand Laterality Judgment Task implemented via the Recognise™ mobile application. Participants will be asked to identify whether displayed hand images represent the left or right hand. Response time and accuracy will be recorded and used for analysis.

    Measured: At baseline (single assessment at study enrollment)

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted3 Mar 2026
  2. Study start12 Nov 2022
  3. Primary completion29 Apr 2023
  4. Study completion29 Jun 2023

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Other
Time perspective
Cross-sectional
Enrolment
37 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07445165
Sponsor's protocol ID
ArelETK-2023/08
Acronym
MI-BA-JPS
Status last verified
Aug 2023
First submitted
12 Mar 2024
Last updated
3 Mar 2026
Results posted
No
Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Undecided

Questions about this trial

What is this clinical trial studying?

An observational study of Neurologic Deficits, run by Istanbul Arel University at 1 site in Turkey (Türkiye).

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 8 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 3 Mar 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Turkey (Türkiye). Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Motor Imagery Ability Assessed by the Movement Imagery Questionnaire-3 (MIQ-3) (time frame: At baseline (single assessment at study enrollment)). The study lists 3 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 3 Mar 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in